Risks of less common cancers in proven mutation carriers with lynch syndrome

Journal of Clinical Oncology

Volumn 30, Issue 35, 2012, Pages 4409-4415

  Engel, Christoph ^a   Loeffler, Markus ^a   Steinke, Verena ^b   Rahner, Nils ^c   Holinski Feder, Elke ^d   Dietmaier, Wolfgang ^e   Schackert, Hans K ^f   Goergens, Heike ^f   Von Knebel Doeberitz, Magnus ^g   Goecke, Timm O ^c   Schmiegel, Wolff ^h   Buettner, Reinhard ⁱ   Moeslein, Gabriela ^j   Letteboer, Tom G W ^k   Goḿez García, Encarna ^l   Hes, Frederik J ^m   Hoogerbrugge, Nicoline ⁿ   Menko, Fred H ^o   Van Os, Theo A M ^p   Sijmons, Rolf H ^r   Wagner, Anja ^s   Kluijt, Irma ^q   Propping, Peter ^b   Vasen, Hans F A ^m   more..

^a UNIVERSITY OF LEIPZIG   (Germany)

^b UNIVERSITY OF BONN   (Germany)

^c UNIVERSITY HOSPITAL DÜSSELDORF   (Germany)

^d LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^e UNIVERSITY OF REGENSBURG   (Germany)

^f DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

^g UNIVERSITY OF HEIDELBERG   (Germany)

^h RUHR UNIVERSITY BOCHUM   (Germany)

ⁱ UNIVERSITY HOSPITAL OF COLOGNE   (Germany)

^j HELIOS St Josefs Hospitals   (Germany)

^k UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^l MAASTRICHT UNIVERSITY   (Netherlands)

^m LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

ⁿ RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^o VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^p ACADEMIC MEDICAL CENTER   (Netherlands)

^q ANTONI VAN LEEUWENHOEK HOSPITAL   (Netherlands)

^r UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^s ERASMUS MEDICAL CENTER   (Netherlands)

more..

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN MLH1; PROTEIN MSH2; PROTEIN MSH6;

ADULT; AGED; ARTICLE; BLADDER CANCER; BREAST CANCER; CALCULATION; CANCER INCIDENCE; CANCER RISK; COHORT ANALYSIS; FEMALE; GENE MUTATION; HEREDITARY NONPOLYPOSIS COLORECTAL CANCER; HUMAN; MAJOR CLINICAL STUDY; MALE; OVARY CANCER; PRIORITY JOURNAL; PROSTATE CANCER; RETROSPECTIVE STUDY; RISK ASSESSMENT; SEX DIFFERENCE; SMALL INTESTINE CANCER; STOMACH CANCER; TRANSITIONAL CELL CARCINOMA;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ADULT; AGED; COHORT STUDIES; COLORECTAL NEOPLASMS, HEREDITARY NONPOLYPOSIS; DNA-BINDING PROTEINS; FEMALE; GERMANY; HUMANS; MALE; MIDDLE AGED; MUTATION; MUTS HOMOLOG 2 PROTEIN; NEOPLASMS; NETHERLANDS; NUCLEAR PROTEINS; REGISTRIES; RETROSPECTIVE STUDIES; RISK FACTORS;

EID: 84870747205     PISSN: 0732183X     EISSN: 15277755     Source Type: Journal    
DOI: 10.1200/JCO.2012.43.2278     Document Type: Article

References (29)

1. Vasen HF: Review article: The Lynch syndrome (hereditary nonpolyposis colorectal cancer). Aliment Pharmacol Ther 26:113-126, 2007 (suppl 2)
2. Aarnio M, Sankila R, Pukkala E, et al: Cancer risk in mutation carriers of DNA-mismatch-repair genes. Int J Cancer 81:214-218, 1999 (Pubitemid 29144749)
3. Bonadona V, Bonaïti B, Olschwang S, et al: Cancer risks associated with germline mutations in MLH1, MSH2, and MSH6 genes in Lynch syndrome. JAMA 305:2304-2310, 2011
4. Kastrinos F, Mukherjee B, Tayob N, et al: Risk of pancreatic cancer in families with Lynch syndrome. JAMA 302:1790-1795, 2009
5. Grindedal EM, Møller P, Eeles R, et al: Germline mutations in mismatch repair genes associated with prostate cancer. Cancer Epidemiol Biomarkers Prev 18:2460-2467, 2009
6. Scott RJ, McPhillips M, Meldrum CJ, et al: Hereditary nonpolyposis colorectal cancer in 95 families: Differences and similarities between mutationpositive and mutation-negative kindreds. Am J Hum Genet 68:118-127, 2001 (Pubitemid 32048366)
7. van der Post RS, Kiemeney LA, Ligtenberg MJ, et al: Risk of urothelial bladder cancer in Lynch syndrome is increased, in particular among MSH2 mutation carriers. J Med Genet 47:464-470, 2010
8. Schulmann K, Engel C, Propping P, et al: Small bowel cancer risk in Lynch syndrome. Gut 57:1629-1630, 2008
9. Watson P, Vasen HF, Mecklin JP, et al: The risk of extra-colonic, extra-endometrial cancer in the Lynch syndrome. Int J Cancer 123:444-449, 2008 (Pubitemid 351842032)
10. Capelle LG, Van Grieken NC, Lingsma HF, et al: Risk and epidemiological time trends of gastric cancer in Lynch syndrome carriers in the Netherlands. Gastroenterology 138:487-492, 2010
11. Baglietto L, Lindor NM, Dowty JG, et al: Risks of Lynch syndrome cancers for MSH6 mutation carriers. J Natl Cancer Inst 102:193-201, 2010
12. Barrow E, Robinson L, Alduaij W, et al: Cumulative lifetime incidence of extracolonic cancers in Lynch syndrome: A report of 121 families with proven mutations. Clin Genet 75:141-149, 2009
13. Goecke T, Schulmann K, Engel C, et al: Genotype-phenotype comparison of German MLH1 and MSH2 mutation carriers clinically affected with Lynch syndrome: A report by the German HNPCC Consortium. J Clin Oncol 24:4285-4292, 2006 (Pubitemid 46630786)
14. Mangold E, Pagenstecher C, Friedl W, et al: Spectrum and frequencies of mutations in MSH2 and MLH1 identified in 1,721 German families suspected of hereditary nonpolyposis colorectal cancer. Int J Cancer 116:692-702, 2005 (Pubitemid 41099700)
15. Vasen HF, den Hartog Jager FC, Menko FH, et al: Screening for hereditary non-polyposis colorectal cancer: A study of 22 kindreds in The Netherlands. Am J Med 86:278-281, 1989 (Pubitemid 19081468)
16. Vasen HF, Stormorken A, Menko FH, et al: MSH2 mutation carriers are at higher risk of cancer than MLH1 mutation carriers: A study of hereditary nonpolyposis colorectal cancer families. J Clin Oncol 19:4074-4080, 2001 (Pubitemid 32976695)
17. Vasen HF, Mecklin JP, Khan PM, et al: The International Collaborative Group on Hereditary Non-Polyposis Colorectal Cancer (ICG-HNPCC). Dis Colon Rectum 34:424-425, 1991
18. Vasen HF, Watson P, Mecklin JP, et al: New clinical criteria for hereditary nonpolyposis colorectal cancer (HNPCC, Lynch syndrome) proposed by the International Collaborative group on HNPCC. Gastroenterology 116:1453-1456, 1999 (Pubitemid 29258894)
19. Rodriguez-Bigas MA, Boland CR, Hamilton SR, et al: A National Cancer Institute Workshop on Hereditary Nonpolyposis Colorectal Cancer Syndrome: Meeting highlights and Bethesda guidelines. J Natl Cancer Inst 89:1758-1762, 1997
20. Umar A, Boland CR, Terdiman JP, et al: Revised Bethesda Guidelines for hereditary nonpolyposis colorectal cancer (Lynch syndrome) and microsatellite instability. J Natl Cancer Inst 96:261-268, 2004 (Pubitemid 38256271)
21. Carayol J, Khlat M, Maccario J, et al: Hereditary non-polyposis colorectal cancer: Current risks of colorectal cancer largely overestimated. J Med Genet 39:335-339, 2002 (Pubitemid 34526354)
22. Ferlay J, Parkin DM, Steliarova-Foucher E: Estimates of cancer incidence and mortality in Europe in 2008. Eur J Cancer 46:765-781, 2010
23. ten Kate GL, Kleibeuker JH, Nagengast FM, et al: Is surveillance of the small bowel indicated for Lynch syndrome families? Gut 56:1198-1201, 2007 (Pubitemid 47300418)
24. Diergaarde B, Braam H, Vasen HF, et al: Environmental factors and colorectal tumor risk in individuals with hereditary nonpolyposis colorectal cancer. Clin Gastroenterol Hepatol 5:736-742, 2007
25. Winkels RM, Botma A, Van Duijnhoven FJ, et al: Smoking increases the risk for colorectal adenomas in patients with Lynch syndrome. Gastroenterology 142:241-247, 2012
26. Botma A, Nagengast FM, Braem MG, et al: Body mass index increases risk of colorectal adenomas in men with Lynch syndrome: The GEOLynch cohort study. J Clin Oncol 28:4346-4353, 2010
27. Pande M, Lynch PM, Hopper JL, et al: Smoking and colorectal cancer in Lynch syndrome: Results from the Colon Cancer Family Registry and the University of Texas M.D. Anderson Cancer Center. Clin Cancer Res 16:1331-1339, 2010
28. Watson P, Ashwathnarayan R, Lynch HT, et al: Tobacco use and increased colorectal cancer risk in patients with hereditary nonpolyposis colorectal cancer (Lynch syndrome). Arch Intern Med 164:2429-2431, 2004 (Pubitemid 39628069)
29. Chao EC, Lipkin SM: Molecular models for the tissue specificity of DNA mismatch repair-deficient carcinogenesis. Nucleic Acids Res 34:840-852, 2006 (Pubitemid 43380669)